← SynDRA
GSK-J4
SynDRA canonical compound SYN0087414 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | KDM6A |
|---|
| Mechanism of action | Histone lysine demethylase inhibitor |
|---|
All known targets
- KDM6A
- KDM6B
- KDM5B
- KDM5C
- TNF
Mechanisms of action (all sources)
- Histone lysine demethylase inhibitor
- KDM5B INHIBITOR
- KDM5C INHIBITOR
- KDM6A INHIBITOR
- KDM6B INHIBITOR
Cross-references
Synonyms
- GSK J4 HCL
- GSK-J1 PRO-DRUG
- GSKJ4
- GTPL8979
- GSKJ4 compound
- RefChem:144533
- GSK-J4 HCl
- MFCD22683852
- GSK-J4 hydrochloride
- GSK-J1 Pro-Drug
- GSK-J4 free base
- orb1697740
- SCHEMBL14931829
- SCHEMBL29373519
- SCHEMBL29409168
- CHEBI:95077
- BDBM50483927
- EBC-07674
- HB1407
- HY-15648B
- AKOS024458241
- CS-3986
- GSK-J4, >=98% (HPLC)
- SB19351
- NCGC00344626-13
- AC-32705
- AS-78162
- BG162626
- DA-63950
- EN300-126002
- F799770
- BRD-K98203492-001-01-1
- BRD-K98203492-003-04-1
- GSK-J4 free base; GSK-J-4; GSK-J 4; GSK-J4
- Z1543021064
- orb1302901
- CS-0066940
- DA-73932
Look up GSK-J4 in the interactive SynDRA portal →